All In MedTech

FDA Clearance Tracker · P140013-S016

Minerva Endometrial Ablation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 14, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140013-S016
Device name
Minerva Endometrial Ablation System
Applicant location
Jacksonville, FL
Received
Oct 4, 2024
Decided
Apr 14, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P140013

Device type

Device class
Class III

Every decision under product code MNB

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site, Scientific Molding Corporation in El Coyol Alajuela, Costa Rica (SMC – Costa Rica), for the Minerva ES Disposable Handpiece for the Minerva Endometrial Ablation System

Source documents

Other decisions for Axora Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.